◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
KOBAYASHI PHARMACEUTICAL CO.,LTD. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 09, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
+Operating Income 9.5B -- 10.4B -- -- --
Operating Margin % 90.8% -- 93.1% -- -- --
+Ordinary Income 10.4B -- 11.2B -- -- --
Revenue Growth % -- -- -- -- -- --
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 09, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
Current Assets 144.5B -- 158.3B -- -- --
Total Assets 265.4B 261.3B 267.5B 270.9B 250.8B 234.0B
Current Liabilities 46.4B -- 56.1B -- -- --
Total Liabilities 51.9B 56.3B 62.7B 56.3B 51.4B 48.0B
Total Equity 213.5B 205.0B 204.8B 214.6B 199.4B 186.0B
Equity Ratio -- 0.78 -- 0.79 0.79 0.80
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...